GlassScriptPhysician profile
Timothy Bradley
NPI 1851394746
$5,251.64
in general payments reported to CMS, 2019-2025
13 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,512 · 2020: $178 · 2021: $1,467 · 2022: $1,473 · 2023: $206 · 2024: $102 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.27 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mvp Orthopedics INC | $2,653.97 | 2019-2021 | |
| Arthrex, INC. | $1,675.63 | 2022-2025 | |
| Depuy Synthes Sales INC. | $222.26 | 2020-2025 | Healix Knotless Peek, Truespan Orthocord |
| Stryker Corporation | $209.12 | 2019-2023 | Variax, T2 |
| Penumbra, INC. | $126.33 | 2023 | Red 72 |
| Medical Device Business Services, INC. | $90.07 | 2021 | |
| Dynasplint Systems INC. | $73.73 | 2021 | |
| Coastal Medical Technologies LLC | $54.57 | 2025 | |
| Biomarin Pharmaceutical INC. | $51.10 | 2019-2024 | Voxzogo 1.2mg |
| Kyowa Kirin, INC. | $41.41 | 2023-2024 | Crysvita |
| Boston Scientific Corporation | $18.47 | 2024 | Eluvia |
| Cranial Technologies, INC | $17.77 | 2025 | Doc Band |
| Pacira Pharmaceuticals Incorporated | $17.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.